Archive \ Volume.17 2026 Issue 1

A Pharmacy Gatekeeping System for Admitting, Restricting, and Withdrawing Clinical Algorithms

, , ,
  1. Department of Pharmacy Algorithm Governance, Faculty of Pharmacy, University of Freiburg, Freiburg, Germany.
  2. Department of Clinical Algorithm Lifecycle Management, Faculty of Pharmacy, Heidelberg University, Heidelberg, Germany.
  3. Department of Gatekeeping and AI Withdrawal, Faculty of Pharmacy, University of Hohenheim, Stuttgart, Germany.

Abstract

Clinical algorithms increasingly influence medication surveillance, alert prioritization, risk estimation, prescription review, and other pharmacy-related decisions. Yet institutions commonly govern their acquisition, technical installation, clinical validation, and day-to-day use through separate processes that do not establish a coherent decision about whether an algorithm should be allowed to enter, remain within, or leave medication-use practice. This article proposes a Pharmacy Algorithm Gatekeeping Architecture that treats algorithmic admission as a continuing institutional governance decision rather than a one-time technical approval. The architecture comprises a Pharmacy Algorithm Dossier, multidisciplinary gatekeeping review, bounded Permission Envelope, monitored-use layer, documented state transitions, and re-entry review. Admission is conditioned on the algorithm’s intended task, users, population, setting, data dependencies, permitted outputs, degree of autonomy, uncertainty handling, safety controls, equity implications, and monitoring readiness. Continuing permission may be narrowed through restriction, interrupted through suspension, or revoked through withdrawal when evidence, performance, workflow, safety, accountability, or implementation conditions become unacceptable. Remediation does not automatically restore permission; re-entry requires a renewed assessment capable of producing different boundaries or rejection. Evaluation must extend beyond model accuracy to calibration, human–AI joint performance, medication-safety consequences, workflow effects, subgroup performance, implementation fidelity, incident detection, and governance traceability. The architecture is an original non-empirical synthesis whose components and transition rules require prospective, comparative, and setting-specific validation. It does not replace regulatory authorization, professional judgment, local legal duties, or clinical accountability, and it does not establish that any admitted algorithm is universally safe, effective, or ready for unrestricted use.


Downloads: 30
Views: 109

How to cite:
Vancouver
Schneider N, Frank T, Müller A, Meier C. A Pharmacy Gatekeeping System for Admitting, Restricting, and Withdrawing Clinical Algorithms. Arch Pharm Pract. 2026;17(1):68-76. https://doi.org/10.51847/u7RohUC21I
APA
Schneider, N., Frank, T., Müller, A., & Meier, C. (2026). A Pharmacy Gatekeeping System for Admitting, Restricting, and Withdrawing Clinical Algorithms. Archives of Pharmacy Practice, 17(1), 68-76. https://doi.org/10.51847/u7RohUC21I

Download Citation
References
  1. Cabitza F, Rasoini R, Gensini GF. Unintended consequences of machine learning in medicine. JAMA. 2017;318(6):517-8. doi:10.1001/jama.2017.7797
  2. Wiens J, Saria S, Sendak M, Ghassemi M, Liu VX, Doshi-Velez F, et al. Do no harm: A roadmap for responsible machine learning for health care. Nat Med. 2019;25(9):1337-40. doi:10.1038/s41591-019-0548-6
  3. Kwan JL, Lo L, Ferguson J, Goldberg H, Diaz-Martinez JP, Tomlinson G, et al. Computerised clinical decision support systems and absolute improvements in care: Meta-analysis of controlled clinical trials. BMJ. 2020;370:m3216. doi:10.1136/bmj.m3216
  4. Co Z, Holmgren AJ, Classen DC, Newmark L, Seger DL, Danforth M, et al. The tradeoffs between safety and alert fatigue: Data from a national evaluation of hospital medication-related clinical decision support. J Am Med Inform Assoc. 2020;27(8):1252-8. doi:10.1093/jamia/ocaa098
  5. Habli I, Lawton T, Porter Z. Artificial intelligence in health care: Accountability and safety. Bull World Health Organ. 2020;98(4):251-6. doi:10.2471/BLT.19.237487
  6. Vollmer S, Mateen BA, Bohner G, Király FJ, Ghani R, Jonsson P, et al. Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness. BMJ. 2020;368:l6927. doi:10.1136/bmj.l6927
  7. Benjamens S, Dhunnoo P, Meskó B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: An online database. NPJ Digit Med. 2020;3:118. doi:10.1038/s41746-020-00324-0
  8. Wu E, Wu K, Daneshjou R, Ouyang D, Ho DE, Zou J. How medical AI devices are evaluated: Limitations and recommendations from an analysis of FDA approvals. Nat Med. 2021;27(4):582-4. doi:10.1038/s41591-021-01312-x
  9. Greenhalgh T, Wherton J, Papoutsi C, Lynch J, Hughes G, A'Court C, et al. Beyond adoption: A new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up, spread, and sustainability of health and care technologies. J Med Internet Res. 2017;19(11):e367. doi:10.2196/jmir.8775
  10. Wang A, Freeman S, Magrabi F. Governance for safe and responsible AI in healthcare organisations: A scoping review of frameworks. NPJ Digit Med. 2026;9(1):516. doi:10.1038/s41746-026-02679-2
  11. Lekadir K, Frangi AF, Porras AR, Glocker B, Cintas C, Langlotz CP, et al. FUTURE-AI: International consensus guideline for trustworthy and deployable artificial intelligence in healthcare. BMJ. 2025;388:e081554. doi:10.1136/bmj-2024-081554
  12. Gaube S, Suresh H, Raue M, Merritt A, Berkowitz SJ, Lermer E, et al. Do as AI say: Susceptibility in deployment of clinical decision-aids. NPJ Digit Med. 2021;4(1):31. doi:10.1038/s41746-021-00385-9
  13. Vasey B, Nagendran M, Campbell B, Clifton DA, Collins GS, Denaxas S, et al. Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. BMJ. 2022;377:e070904. doi:10.1136/bmj-2022-070904
  14. Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378. doi:10.1136/bmj-2023-078378
  15. Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW, Bossuyt PMM, et al. Calibration: The Achilles heel of predictive analytics. BMC Med. 2019;17(1):230. doi:10.1186/s12916-019-1466-7
  16. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447-53. doi:10.1126/science.aax2342
  17. Feng J, Phillips RV, Malenica I, Bishara A, Hubbard AE, Celi LA, et al. Clinical artificial intelligence quality improvement: Towards continual monitoring and updating of AI algorithms in healthcare. NPJ Digit Med. 2022;5(1):66. doi:10.1038/s41746-022-00611-y
  18. Davis SE, Lasko TA, Chen G, Siew ED, Matheny ME. Calibration drift in regression and machine learning models for acute kidney injury. J Am Med Inform Assoc. 2017;24(6):1052-61. doi:10.1093/jamia/ocx030
  19. Kore A, Abbasi Bavil E, Subasri V, Abdalla M, Fine B, Dolatabadi E, et al. Empirical data drift detection experiments on real-world medical imaging data. Nat Commun. 2024;15(1):1887. doi:10.1038/s41467-024-46142-w
  20. Roschewitz M, Khara G, Yearsley J, Sharma N, James JJ, Ambrózay É, et al. Automatic correction of performance drift under acquisition shift in medical image classification. Nat Commun. 2023;14(1):6608. doi:10.1038/s41467-023-42396-y
  21. Ghassemi M, Naumann T, Schulam P, Beam AL, Chen IY, Ranganath R. Practical guidance on artificial intelligence for health-care data. Lancet Digit Health. 2019;1(4):e157-9. doi:10.1016/S2589-7500(19)30084-6
  22. Kiani A, Uyumazturk B, Rajpurkar P, Wang A, Gao R, Jones E, et al. Impact of a deep learning assistant on the histopathologic classification of liver cancer. NPJ Digit Med. 2020;3(1):23. doi:10.1038/s41746-020-0232-8
  23. Tschandl P, Rinner C, Apalla Z, Argenziano G, Codella N, Halpern A, et al. Human-computer collaboration for skin cancer recognition. Nat Med. 2020;26(8):1229-34. doi:10.1038/s41591-020-0942-0
  24. Kompa B, Snoek J, Beam AL. Second opinion needed: Communicating uncertainty in medical machine learning. NPJ Digit Med. 2021;4(1):4. doi:10.1038/s41746-020-00367-3
  25. Graafsma J, Murphy RM, van de Garde EMW, Karapinar-Çarkit F, Derijks HJ, Hoge RHL, et al. The use of artificial intelligence to optimize medication alerts generated by clinical decision support systems: A scoping review. J Am Med Inform Assoc. 2024;31(6):1411-22. doi:10.1093/jamia/ocae076
  26. Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci. 2022;17(1):75. doi:10.1186/s13012-022-01245-0
  27. Hussain MI, Reynolds TL, Zheng K. Medication safety alert fatigue may be reduced via interaction design and clinical role tailoring: A systematic review. J Am Med Inform Assoc. 2019;26(10):1141-9. doi:10.1093/jamia/ocz095
  28. Challen R, Denny J, Pitt M, Gompels L, Edwards T, Tsaneva-Atanasova K. Artificial intelligence, bias and clinical safety. BMJ Qual Saf. 2019;28(3):231-7. doi:10.1136/bmjqs-2018-008370
  29. Ghassemi M, Oakden-Rayner L, Beam AL. The false hope of current approaches to explainable artificial intelligence in health care. Lancet Digit Health. 2021;3(11):e745-50. doi:10.1016/S2589-7500(21)00208-9
  30. Zech JR, Badgeley MA, Liu M, Costa AB, Titano JJ, Oermann EK. Variable generalization performance of a deep learning model to detect pneumonia in chest radiographs: A cross-sectional study. PLoS Med. 2018;15(11):e1002683. doi:10.1371/journal.pmed.1002683

 

 


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.